Skip to content
Tenfell
Awarded contract
Published 23 Feb 2021

Contract award – The NHS Commissioning Board (operating under the name of NHS England)

The NHS Commissioning Board (operating under the name of NHS England) · United Kingdom

Key facts

Awarded
25 Jan 2021
Contract starts
01 Mar 2021
Contract ends
28 Feb 2022
Procedure
Open procedure (framework)
Buyer type
Health

Awarded to 37 suppliers

SupplierValue
Accord-UK Ltd—
Aventis Pharma Ltd T/A Sanofi—
Bayer plc—
Biogen—
Bristol Myers Squibb—
Celltrion Healthcare United Kingdom Limited—
CST Pharma Ltd—
Daiichi Sankyo UK Ltd—
Day Lewis Medical Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Eli Lilly & Company Ltd—
LEO Pharma Ltd—
Ferring Pharmaceuticals Limited—
Gilead Sciences Limited—
Ipsen—
Merck Serono Limited—
Merck Sharpe & Dohme (UK) Limited—
Mylan—
Napp Pharmaceuticals—
Novo Nordisk—
Roche Products Ltd—
ROVI Biotech Ltd—
Novartis Pharmaceuticals UK Ltd—
Pfizer Ltd—
Sandoz Ltd—
Techdow Pharma England Ltd—
Takeda UK Limited—
Teva UK Ltd—
UL Global Pharma—
AstraZeneca—
Amgen Ltd—
Gedeon Richter UK Ltd—
Thornton & Ross Ltd—
UCB Pharma Ltd—
Janssen-Cilag Ltd—
Organon Pharma (UK) Ltd.—
Sobi (Swedish Orphan Biovitrum Ltd)—

Categories (CPV)

Similar open tenders

About The NHS Commissioning Board (operating under the name of NHS England)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.